REFERENCES
1. Daruich A, Matet A, Moulin A, et al. Mechanisms of macular edema: Beyond the surface. Prog Retin Eye Res . 2018;63:20-68.
2. Carreira AR, Marques N, Carreira P, et al. Safety of intravitreal triamcinolone and its impact on optic nerve morphology in patients treated for diabetic macular edema. Eur J Ophthalmol . 2022;32(3):1596-1601.
3. Vujosevic S, Midena E. Controversies in Pharmacological Treatment of Inflammatory Component of Macular Edema. Curr Pharm Des . 2015;21(32):4688-93.
4. Golan S, Loewenstein A. Surgical treatment for macular edema.Semin Ophthalmol . Jul 2014;29(4):242-56.
5. Tang B, Wang X, Luo Y, Li Z, He Y. Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery. Evid Based Complement Alternat Med . 2022;2022:5606343.
6. Huang L, Zhang Z, Yao T, Gao X, Dan Y, He Y. The 100 top-cited articles in macular edema from 1950 to 2020. Semin Ophthalmol . 2022;37(2):203-207.
7. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica . 2019;242(3):123-162.
8. Chhablani J, Wong K, Tan GS, et al. Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines. Asia Pac J Ophthalmol (Phila) . 2020;9(5):426-434.
9. Valdes LM, Sobrin L. Uveitis Therapy: The Corticosteroid Options.Drugs . 2020;80(8):765-773.
10. Jea SY, Byon IS, Oum BS. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis. Korean J Ophthalmol . 2006;20(2):99-103.
11. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.Clin Experiment Ophthalmol . 2001;29(1):2–6 .
12. Ibrahim MG, Salman A, Said AA, et al. Efficacy of posterior sub-tenon’s capsule injection compared to intravitreal injection of triamcinolone acetonide for treatment of diabetic macular edema: A systematic review and meta-analysis. Egypt Retin J.2021;8(1):2347-5617.
13. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.Ann Intern Med . (2015) 162:777–84.
14. Higgins JP, Savović J, Page MJ, et al. Chapter 8: Assessing risk of bias in a randomized trial. Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020). The Cochrane 15 Collaboration, 2020. Available at: https://training.cochrane.org/handbook/current/chapter-08/.
15. Brignardello-Petersen R, Florez ID, Izcovich A, et al. GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework. BMJ . 2020; 371: m3900.
16. Hultcrantz M, Rind D, Akl EA, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol . 2017;87:4–13.
17. Zeng L, Brignardello-Petersen R, Hultcrantz M, et al. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings. J Clin Epidemiol . 2021;137: 163–175.
18. Multinma: Bayesian Network Meta-Analysis of Individual and Aggregate Data [program]. R package version 4.1.3 version (2020).
19. Greco T, Landoni G, Biondi-Zoccai G, et al. A Bayesian network meta-analysis for binary outcome: how to do it. Stat Methods Med Res . 2016;25:1757–1773.
20. Valkenhoef GV, Dias S, Ades AE, et al. Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis. Res Synth Methods. 2016;7:80–93 .
21. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol . 2011;64:163–71.
22. Abdelshafy TA, Tawfik ST, Anany EM, et al. A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane. J Ophthalmol . 2022;2022:7947710.
23. Bonini-Filho MA, Jorge R, Barbosa JC, et al. Intravitreal injection versus sub-Tenon’s infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci. 2005;46(10):3845-3859.
24. Cardillo JA, Melo LA, Jr., Costa RA, et al. Comparison of intravitreal versus posterior sub-Tenon’s capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.Ophthalmology . 2005;112(9):1557-1563.
25. El-Sayed S, Ellakwa AA, Badawi NM, et al. Intravitreal versus subtenon injection of triamcinolone acetonide for diabetic macular edema. Menoufia Med J. 2014;27:636–664.
26. Gillies MC, McAllister IL, Zhu M, et al. Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. Invest. Ophthalmol Vis Sci . 2010;51(5):2322-2328.
27. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. American journal of ophthalmology . Jun 2005;139(6):972-82.
28. Li SY, Miao L, Chen H, et al. Efficacy and safety of combination treatment with triamcinolone acetonide retrobulbar injection and panretinal photocoagulation in diabetic macular edema. [Chinese].J Jilin Univer Med Edi. 2014;40(6):1289-1292.
29. Luo D, Zhu B, Zheng Z, et al. Subtenon Vs Intravitreal Triamcinolone injection in Diabetic Macular Edema, A prospective study in Chinese population. Pak J Med Sci . 2014;30(4):749-754.
30. Marey H, Ellakwa AF. Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema. Clin Ophthalmology . 2011;5:1011-6.
31. Moon J, Kim M, Sagong M. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.Eye (London, England) . 2016;30(8):1084-1090.
32. Rakhee A, Ajay A, Sagdeo M. Effect of combined Intravitreal Injections of Bevacizumab and Triamcinolone Acetonide vs intravitreal Bevacizumab in Diffuse Diabetic Macular Edema. J Med Dent Sci.2014(13):01-06.
33. Saleh MA, Abdelmoneim M, Fahmy H, et al. Posterior subtenon versus intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Curr Med Res Pract . 2017;2(2):141.
34. Soliman Mohamed A, Hamed AA, Nehad T, Islam M, Metawee AA. Comparison between the effects of intravitreal and posterior subtenon injection of triamcinolone acetonide for treatment of diabetic macular edema. Benha Med J.2018;35:13-19.
35. Takata C, Messias A, Folgosa MS, et al. Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.Retina. 2010;30(4):562-569.
36. Wickremasinghe SS, Rogers SL, Gillies MC, et al. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Invest Ophthalmol Vis Sci. 2008;49(11):4707-4711.
37. Zakaria YG, Salman AG, Said AMA, et al. Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema. Clin Ophthalmol. 2022;16:733-746.
38. Chhablani J, Wong K, Tan GS, et al. Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines.Asia Pac J Ophthalmol (Phila) . 2020;9(5):426-434.
39. American Diabetes Association Professional Practice Committee (2022). 12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022. Diabetes Care . 2022; 45(Suppl 1), S185-S194.
40. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica.2019;242(3),123-162.
41. Yuksel-Elgin C, Elgin C. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis.Int J Ophthalmol . 2016 Jan 18;9(1):139-144.
42 Wykoff CC, Khurana RN, Lampen SIR, et al. Suprachoroidal triamcinolone acetonide for diabetic macular edema: the HULK trial. Ophthalmol Retina . 2018;2:874–877.
43 Barakat MR, Wykoff CC, Gonzalez V, et al. Suprachoroidal CLS-TA plus intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study. Ophthalmol Retina . 2021;5(1):60–70.
44 Maggio E, Mete M, Polito A, et al. Retrobulbar triamcinolone for inflammatory choroidal neovascularization in pregnancy. BMC Ophthalmol . 2020;20(1):483.
45 Grzybowski A, Kanclerz P. The Role of Steroids and NSAIDs in Prevention and Treatment of Postsurgical Cystoid Macular Edema.Curr Pharm Des . 2018;24(41):4896-4902.
46 Wykrota AA, Abdin AD, Munteanu C, et al. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases. Graefes Arch Clin Exp Ophthalmol.2023;